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PINK1-mediated phosphorylation of LETM1
regulates mitochondrial calcium transport and
protects neurons against mitochondrial stress
En Huang1, Dianbo Qu1, Tianwen Huang1, Nicoletta Rizzi2, Wassamon Boonying1, Dorothy Krolak1, Paolo Ciana3,
John Woulfe4, Christine Klein5, Ruth S. Slack1, Daniel Figeys6 & David S. Park 1
Mutations in PTEN-induced kinase 1 (PINK1) result in a recessive familial form of Parkinson’s
disease (PD). PINK1 loss is associated with mitochondrial Ca2+ mishandling, mitochondrial
dysfunction, as well as increased neuronal vulnerability. Here we demonstrate that PINK1
directly interacts with and phosphorylates LETM1 at Thr192 in vitro. Phosphorylated LETM1
or the phospho-mimetic LETM1-T192E increase calcium release in artiﬁcial liposomes and
facilitates calcium transport in intact mitochondria. Expression of LETM1-T192E but not
LETM1-wild type (WT) rescues mitochondrial calcium mishandling in PINK1-deﬁcient neu-
rons. Expression of both LETM1-WT and LETM1-T192E protects neurons against
MPP+–MPTP-induced neuronal death in PINK1 WT neurons, whereas only LETM1-T192E
protects neurons under conditions of PINK1 loss. Our ﬁndings delineate a mechanism by
which PINK1 regulates mitochondrial Ca2+ level through LETM1 and suggest a model by
which PINK1 loss leads to deﬁcient phosphorylation of LETM1 and impaired mitochondrial
Ca2+ transport..
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PTEN-induced kinase 1 (PINK1) is a mitochondria targetedserine/threonine kinase. Mutations in PINK1 can causerecessive familial Parkinson’s disease (PD)1, 2. Under basal
conditions, PINK1 is imported into the inner mitochondrial
membrane, where it is processed by mitochondrial proteases3–5.
However, upon mitochondrial membrane depolarization or
damage, PINK1 accumulates on the outer membrane of mito-
chondria, where it recruits Parkin to trigger a mitophagic path-
way of quality control6. Whether PINK1 exerts a biological
function endogenously at the inner mitochondrial membrane is
unknown. Previous evidence demonstrates that PINK1 loss
results in mitochondrial dysfunction, reduced complex I activity,
increased oxidative damage7, 8, mitochondrial Ca2+ ([Ca2+]m)
mishandling and accumulation9–11, and increase in mPTP
opening11, 12. One interpretation is that these changes may render
dopaminergic (DA) neurons more vulnerable to stress and
thereby contribute to the pathogenesis of PD13, 14.
To better deﬁne the mechanism(s) by which PINK1 may
function at the mitochondria, we performed a mass spectrometry-
based interactomics screen for potential PINK1-interacting pro-
teins15, 16. One identiﬁed target is the leucine zipper-EF-hand
containing transmembrane protein 1(LETM1), which was
recently proposed as a Ca2+/H+ antiporter by a genome-wide
RNAi screen17. LETM1 is a mitochondrial inner membrane
protein18 and several reports suggest that it mediates mitochon-
drial Ca2+ uptake and extrusion in a gradient-dependent man-
ner17, 19, 20. In this regard, knockdown of LETM1 compromises
the rate of mitochondrial Ca2+ uptake and extrusion, leading to
an alteration of mitochondrial bioenergetics, metabolic signaling,
and sensitization to cell death19–21. However, others have sug-
gested that LETM1 plays an essential role in mitochondrial K+
homeostasis by mediating the mitochondrial K+/H+ exchange22.
Our study indicates that LETM1 is a substrate of PINK1 and
that LETM1 plays a critical role in protecting neurons from
exogenous stress. Importantly, we also provide evidence that
PINK1-mediated phosphorylation of LETM1 is crucial for its
reported capacity for mitochondrial Ca2+ regulation and neuronal
survival effects. Taken together, our data provide a compelling
model by which PINK1 at the inner mitochondrial membrane
performs a critical function of regulating LETM1 function.
Results
PINK1 phosphorylates LETM1 at Thr192. We initially identi-
ﬁed LETM1 as one of the PINK1-interacting candidates through
an unbiased interaction screen. Brieﬂy, PINK1-FLAG was
expressed in HEK293 cells and immunoprecipitated. Interacting
proteins were determined by mass spectrometry-based inter-
actomics as previously reported15, 16. Analysis of the data set
suggested LETM1 as one of the PINK1-interacting candidates
with a Mascot score of 85. To validate this initial ﬁnding, we
performed co-immunoprecipitation (Co-IP) analyses with
expression of FLAG-tagged PINK1 and Myc-tagged LETM1 in
HEK293 Cells (ATCC). As shown in Fig. 1a, Co-IP for Myc-
LETM1 with anti-Myc antibody followed by Western blot (WB)
analyses for FLAG-PINK1 with anti-FLAG antibody demon-
strated a speciﬁc interaction. The reverse Co-IP also supported
the interaction (Fig. 1b). We further conﬁrmed the interaction of
endogenous PINK1 with LETM1 from human post-mortem brain
(Fig. 1c, d) and human SH-SY5Y neuroblastoma cells (Supple-
mentary Fig. 1a, b). We next examined whether LETM1 may be a
kinase substrate of PINK1. To test this, endogenous LETM1 from
HEK293 cells expressing GFP or PINK1 was IPed with an anti-
LETM1 antibody and probed with phospho-Thr and phospho-
Ser antibodies by WB analyses. The results suggested that LETM1
was phosphorylated at threonine residues (Fig. 1e) but not serine
(Supplementary Fig. 1c) in cells expressing PINK1 but not GFP.
PINK1 distributes in the outer membrane, inner membrane, and
intermembrane space of mitochondria but not in the matrix of
mitochondria4, 23, 24. When localized at the inner mitochondrial
membrane, its kinase domain likely faces the intermembrane
space4. LETM1 is also a mitochondrial inner membrane protein
with a single transmembrane domain. Its N-terminus is exposed
to the intermembrane space, whereas its C-terminus is located in
the matrix18, 21. Therefore, we hypothesized that PINK1 might
phosphorylate the N-terminal region of LETM1 (residue 1–204).
We searched for potential Thr phosphorylation sites of LETM1 in
this region and identiﬁed two potential conserved motifs, Thr175
and Thr192, which were conserved in multiple species (Supple-
mentary Fig. 2). Of these two sites, Thr192 was conserved in all
seven species examined. We constructed and isolated bacterially
expressed GST tagged N-terminus of LETM1-WT (residue 1–204,
GST-N-LETM1) and mutations with the T175 or T192 site
mutated singly to alanine. These constructs were analyzed by an
in vitro kinase assay with His-tagged PINK1 with the N-terminus
truncated to promote stability and kinase activity (deleted resi-
dues 1–111, His-ΔN-PINK1). The results showed that PINK1
phosphorylated the WT and T175A but not T192A fragments,
indicating that Thr192 of LETM1 is an appropriate candidate
phosphorylation site for PINK1 (Fig. 1f). For further validation,
we generated a custom phospho-antibody speciﬁc for phos-
phorylated LETM1 at Thr192 (pT192). We generated His-tagged
LETM1 with the transmembrane portion deleted (His-ΔTM-
LETM1) to enhance recovery of bacterially generated LETM1.
The pT192 antibody speciﬁcally recognized LETM1-WT phos-
phorylated by PINK1 but not unphosphorylated LETM1-WT or
the T192A mutant incubated with PINK1 (Fig. 1g). Importantly,
the pT192 phospho-antibody generated signal was blocked by
pre-incubation with the corresponding phosphopeptide (p-pep-
tide) antigen (CNGHTLpT192RRERR) (Fig. 1g, right) but not
with the homologous non-p-peptide (CNGHTLTRRERR)
(Fig. 1g, left). In addition, kinase-dead mutant K219M did not
phosphorylate LETM1 (Supplementary Fig. 1d). Calf-intestinal
alkaline phosphatase (CIP) treatment of phospho-LETM1 elimi-
nated the phosphorylation signal (Fig. 1h). These data support
the speciﬁcity of our generated pT192 antibody.
Phospho-LETM1 is decreased in PINK1 KO and Q456X
mutant. To further conﬁrm whether phosphorylation of LETM1
at Thr192 is dependent on endogenous PINK1, we utilized our
pT192 phospho-antibody to detect phospho-LETM1 in PINK1
WT and knockout (KO) mouse embryo ﬁbroblasts (Fig. 2a) and
mouse brain tissues (Fig. 2b). Our results clearly showed that
phosphorylation of LETM1 at Thr192 occurs in a PINK1-
dependent manner. Similarly, we analyzed for pT192 signal in
ﬁbroblasts obtained from a PD patient expressing PINK1-Q456X,
a nonsense mutant identiﬁed from PD patients with a partial
deletion of the kinase domain resulting in a reduction in its kinase
activity. LETM1 phosphorylation was dramatically reduced when
compared to normal control individual (Fig. 2c). Conversely,
expression of PINK1-Q456X in HEK293 cells also demonstrated
reduced phosphorylation of LETM1 at Thr192 when compared to
expression of PINK1 WT (Fig. 2d). Finally, PINK1 is stabilized at
the outer mitochondrial membrane upon mitochondrial stress,
topographically eliminating its ability to phosphorylate LETM1.
We therefore tested whether mitochondrial damage induced by
rotenone would reduce the pT192 LETM1 signal. Rotenone
treatment stabilized full-length PINK1 as previously reported25.
Importantly, this was associated with the absence of T192
phosphorylation (Fig. 2e). The absence of the T192 signal sug-
gests that full-length PINK1 induced by mitochondrial stress
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previously reported to be stabilized at the outer membrane5, 26
does not phosphorylate LETM1. Taken together, this evidence
strongly supports the PINK1 dependence of T192 LETM1
phosphorylation. Our data also support the notion that processed
PINK1 at the inner mitochondrial membrane phosphorylates
LETM1.
Phospho-LETM1 increases the calcium transport in liposomes.
Previous evidence indicated that LETM1 regulates calcium
transport in an artiﬁcial liposomal context17, 27. We therefore ﬁrst
assessed whether phosphorylation of LETM1 at Thr192 might
affect its calcium transport activity in this deﬁned setting. Initi-
ally, bacterially expressed full-length His-LETM1-WT, phospho-
mimetic T175E, and T192E were subjected to a liposomal calcium
release assay. As shown in Fig. 3a, b, the rate of calcium release
regulated by LETM1-T192E was signiﬁcantly higher than the rate
of calcium release regulated by WT and T175E, suggesting the
importance of T192 phosphorylation in calcium exchange activ-
ity. We also performed the converse with calcium uptake in
liposomes. We showed similar results, i.e., that the calcium uptake
activity of His-LETM1-T192E is higher than that of WT or
T175E (Supplementary Fig. 3a, b). Next, we explored whether
phosphorylation of LETM1 at Thr192 affects calcium transport in
liposomes. We puriﬁed FLAG-LETM1 variants expressed in
HEK293 cells coexpressed with PINK1 or GFP control by IP with
anti-FLAG antibody. We conﬁrmed that phosphorylation of
LETM1-WT could be detected in cells contransfected with PINK1
but not with that of LETM1-T192A by our pT192 phospho-
antibody (Fig. 3c). These eluted FLAG-tagged proteins were then
incorporated into liposomes and assessed for calcium release
assay. As shown in Fig. 3d, e, phospho-LETM1-WT(pWT) and
LETM1-T192E showed an increased rate of calcium transport
compared to other conditions (LETM1-WT, T192A without
PINK1 (T192A), and T192A with PINK1(pT192A)). Similarly,
a Input IP: FLAGb
IP: PINK1 Input IgG PINK1
WB: LETM1
WB: PINK1 63K
75K
d
IP: LETM1 GFP PINK1
WB: pThr
WB: LETM1
e f GST-N-LETM1 N WT WT T175A T175A T192A T192A
His- Δ N-PINK1 + – + – + – +
pThr
Coomassie
Blue 
WT T192AWT T192A WT WT 
His-ΔN-PINK1 – + – + – +
pT192
LETM1
+ Non-p-Pep + p-Pep
His-ΔTM-LETM1
g
IP: LETM1 Input IgG LETM1
WB: PINK1
WB: LETM1
63K
75K
Input IP: Myc
c
63K
75K
WB: FLAG
WB: Myc
Myc-LETM1 – + – +
FLAG-PINK1 + + + +
75K
63K
WB: Myc
WB: FLAG
FLAG-PINK1 – + – +
Myc-LETM1 + + + +
h Phospho-LETM1 + +
CIP – +
pT192
LETM1
75K
75K
75K
75K
75K
75K
48K
48K
*
Fig. 1 PINK1 interacts with and phosphorylates LETM1. a Expressed PINK1 interacts with LETM1. HEK293 cells were co-transfected with p3xFLAG-CMV-
PINK1 and pCMV-3Tag-2a LETM1 (Myc-tag) for 1 day. Myc-LETM1 was IPed from cell lysate with anti-Myc antibody and probed with anti-FLAG antibody
by WB. The membrane was reprobed with anti-Myc antibody. b Inversely to a, FLAG-PINK1 protein was IPed with anti-FLAG antibody and probed with
anti-Myc and Anti-FLAG antibodies. * is non-special band. c Endogenous PINK1 interacts with LETM1 in human post-mortem brain tissue. Brain lysate was
IPed with control IgG or anti-LETM1. The precipitated proteins were probed with anti-PINK1 and reprobed with anti-LETM1 antibodies by WB. d Inversely to
c IP was performed with control IgG or anti-PINK1, probed with anti-LETM1 and reprobed with anti-PINK1 antibody by WB. e PINK1 phosphorylates LETM1
at threonine residue(s) in vivo. HEK293 cells were transfected with GFP or pAdtrack-PINK1 for 1 day. LETM1 was IPed with anti-LETM1 antibody, probed
with anti-phospho-Thr and reprobed with anti-LETM1 antibody by WB. f PINK1 phosphorylates LETM1 at Thr192 in vitro. Puriﬁed bacterial GST-N-LETM1
variants (resides 1–204) were subjected to an in vitro kinase assay with bacterial His-ΔN-PINK1 (residues 1–111 deleted) and probed with phospho-Thr
antibody. Coomassie blue staining was performed as loading control for GST-N-LETM1. N: nil. g Bacterial His-ΔN-LETM1 variants were subjected to in vitro
kinase assay with His-ΔN-PINK1 and probed for phospho-LETM1 utilizing the Thr192 (pT192) phospho-antibody. Samples were reprobed with anti-LETM1
for loading. h His-ΔN-LETM1 was incubated with His-ΔN-PINK1 in an in vitro kinase reaction to generate phospho-LETM1. Phospho-LETM1 was then
treated without or with CIP for 2 h then probed with pT192 and reprobed with LETM1 antibody. All above experiments were replicated three times,
respectively
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these eluted FLAG proteins were also subjected to the liposomal
calcium uptake assay. Similar to calcium release assay, the rate of
calcium uptake by phospho-LETM1 and LETM1-T192E was
signiﬁcantly higher than the others (Supplementary Fig. 3c, d).
Taken together, these data indicate that phosphorylation of
LETM1 by PINK1 at Thr192 increases calcium handling in
liposomes.
LETM1-T192E rescues calcium transport in mitochondria. We
next examined the role of LETM1 in mitochondrial calcium
transport in a cellular environment. We initially utilized Rhod-2,
which is cationic and preferentially accumulated into the mito-
chondria28, to observe the dynamic change of [Ca2+]m in primary
cortical neurons. First, we veriﬁed that Rhod-2 was co-localized
with Mitotracker green (a mitochondrial marker) in both
HEK293 cells and primary cortical neurons (Supplementary
Fig. 4), indicating Rhod-2 mainly distributes in mitochondria
under the conditions utilized. We next examined whether PINK1
affects [Ca2+]m in neurons upon stimulation with neuro-
transmitter acetylcholine (Ac). The trace of [Ca2+]m showed an
earlier increase and later decrease with time indicative of calcium
uptake and extrusion, respectively, in mitochondria. As shown in
Supplementary Fig. 5a, b, both rates of [Ca2+]m uptake and
extrusion were compromised in PINK1 KO neurons. We next
examined the effect of small interfering RNA (siRNA) to LETM1
(SiLETM1) in neurons and showed that two independent
SiLETM1 constructs (S2 and S3) reduced the level of LETM1
(Supplementary Fig. 5c). Importantly, SiLETM1-S2 and S3
treatment both decreased [Ca2+]m uptake and extrusion when
compared to control siRNA (Supplementary Fig. 5d, e). To fur-
ther examine the role of phosphorylation of LETM1, we virally
expressed control GFP, LETM1-WT, T192A, or T192E mutants
in PINK1 WT and KO neurons, respectively. First, we examined
whether these viral vectors affect resting mitochondrial mem-
brane potential (Δψm) analyzed by TMRM in PINK1 WT or KO
neurons. Our results show that although the Δψm was slightly
lower in KO compared to WT neurons as previously reported29,
the viral LETM1-WT, T192A, and T192E did not affect resting
Δψm when compared to GFP (Supplementary Fig. 6a). For
resting [Ca2+]m analyzed by Rhod-2, there is no difference
between PINK1 WT and KO neurons as previously reported9 and
the viral LETM1-WT, T192A, and T192E did not affect the
resting [Ca2+]m. (Supplementary Fig. 6b). However, the caveat to
this observation is that differences in Δψm in PINK1 WT and
KO neurons may affect Rhod-2 loading. As shown in Fig. 4a, b,
LETM1-WT and T192E but not LETM1-T192A promoted [Ca2
+]m uptake and extrusion compared to GFP control in PINK1
WT neurons upon Ac stimulation. However, only LETM1-T192E
but not WT and T192A rescued the compromised [Ca2+]m
uptake and extrusion in PINK1 KO neurons (Fig. 4c, d). These
data indicated that PINK1-mediated phospho-LETM1 played a
role in both mitochondrial calcium uptake and extrusion. Given
that mitochondrial calcium uniporter (MCU) complex and
mitochondrial Na+/Ca2+ exchanger (NCLX) also play a role in
mitochondrial calcium uptake and release, respectively30, 31, we
next examined whether there is potential cross-talk between
LETM1 and MCU or NCLX. We performed Co-IP to check the
interaction between LETM1 and MCU or NCLX in HEK293 cells.
As shown in Supplementary Fig. 7, LETM1 did not interact with
MCU (Supplementary Fig. 7a, b) or NCLX (Supplementary
Fig. 7c, d).
Because of some potential issues with Rhod-2-based analyses as
stated above, we further investigated the dynamic change of [Ca2
+]m, employing the mitochondrial genetically encoded calcium
indicator 4XmTG-TN-XXL32. We infected lentiviral 4XmTG-
TN-XXL in neurons and showed that it distributed in
mitochondria co-located with Mitored (Supplementary Fig. 8a).
We also produced lenti-LETM1-3XFLAG-T2A-cherry variants
co-infected with lenti-4XmTG-TN-XXL (Supplementary Fig. 8b).
The expression of lenti-LETM1-3XFLAG-T2A-cherry variants
were also validated by Western blotting (Supplementary Fig. 8c).
As shown in Fig. 4e, f and Supplementary Fig. 9, LETM1-WT and
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were subjected to IP with anti-LETM1, probed with pT192 and reprobed with anti-LETM1 by WB. c Proteins extracted from human ﬁbroblast of control
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were transfected with Adtrack GFP control, AdPINK1-WT, and AdPINK1-Q456X mutant for 1 day. Endogenous LETM1 protein was isolated by IP with anti-
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T192E but not LETM1-T192A promoted [Ca2+]m uptake and
extrusion compared to GFP control in PINK1 WT neurons
infected with lenti-4XmTG-TN-XXL upon Ac stimulation.
However, only LETM1-T192E but not WT and T192A rescued
the compromised [Ca2+]m uptake and extrusion in PINK1 KO
neurons (Fig. 4g, h). Taken together, these data support a model
in which phosphorylation of LETM1 at T192 regulates [Ca2+]m
and defects in calcium management observed with PINK1 loss
can only be rescued by the LETM1-T192E phosphomimic.
Finally, it has been reported that loss of PINK1 compromises
NCLX and lead to impaired mitochondrial Ca2+ extrusion33. To
investigate whether NCLX and LETM1 function in the same
pathway to regulate Ca2+ extrusion in cortical neurons, an NCLX
inhibitor CGP 37157 was employed. This inhibitor delayed [Ca2
+]m extrusion. In the presence of this NCLX inhibition,
expression of LETM1 still increased [Ca2+]m extrusion (Supple-
mentary Fig. 10a, b). Conversely, KD of LETM1 by siRNA S2 or
S3 additionally delayed [Ca2+]m extrusion in Ac-stimulated
neurons in the presence of the NCLX inhibitor CGP 37157
(Supplementary Fig. 10c, d). Taken together, these data indicated
that LETM1 and NCLX are involved in [Ca2+]m extrusion but
likely in an independent manner.
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Fig. 3 The effect of PINK1-mediated phosphorylation of LETM1 on liposomes calcium release activity in vitro. a About 1 µg puriﬁed bacterial full-length His-
LETM1-WT, T175E, and T192E were incorporated into liposomes and subjected to calcium release assay. Control (Con) indicates no proteins incorporated.
b (top panel) Quantiﬁcation of calcium release activity measured by rate of calcium release and calculated as change of ﬂuorescence unit (ΔF). n= 6.
(bottom panel) The liposome samples in a were analyzed by WB with anti-LETM1 antibody to show loading of proteins. c HEK293 cells were co-
transfected with pAdtrack LETM1 (AdLETM1)-WT or T192A and Adtrack control GFP (AdGFP, WT, T192A) or PINK1 (AdPINK1, pWT, pT192A), and
AdLETM1-T192E only for 1 day. The FLAG-LETM1 proteins were isolated by IP with anti-FLAG, probed with pT192 or anti-LETM1 by WB. The experiment
was replicated three times. d HEK293 cells were co-transfected with AdLETM1-WT or T192A and AdGFP or AdPINK1, and AdLETM1-T192E only for 1 day.
The FLAG-LETM1 proteins were isolated by IP with anti-FLAG and eluted by 3XFLAG peptide. The eluted proteins were subjected to calcium release assay
using artiﬁcial liposomes. Control is without protein incorporated. e (top panel) Quantiﬁcation of calcium release activity of d measured by rate of calcium
release and calculated as change of ﬂuorescence unit (ΔF). n= 6. (bottom panel) The liposomes samples in d were subjected to WB with anti-LETM1
antibody to show similar loading of proteins
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Fig. 4 The effect of phospho-LETM1 at Thr192 on mitochondrial calcium transport in primary cortical neurons. a Representative ﬂuorescence traces of
mitochondrial Ca2+ imaging in neurons from PINK1 WT infected with adenovirus GFP, LETM1-WT, T192A, and T192E stimulated by Ac. b Quantiﬁcation of
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from PINK1 KO infected with adenovirus GFP, LETM1-WT, T192A, and T192E stimulated by Ac. d Quantiﬁcation of the rate of calcium transport release
activity in c measured by T1/2. n= 5. e Representative traces of mitochondrial Ca2+ imaging in neurons infected with lenti-4mTG-TN-XXL from PINK1 WT
co-infected with lenti-mitoCherry, LETM1-WT, T192A, and T192E stimulated by Ac. f Quantiﬁcation of the rate of calcium transport in e measured by T1/2.
n= 4. g Representative traces of mitochondrial Ca2+ imaging in neurons infected with lenti-4mTG-TN-XXL from PINK1 KO co-infected with lenti-
mitoCherry, LETM1-3XFLAG-cherry-WT, T192A, and T192E stimulated by Ac. h Quantiﬁcation of the rate of calcium transport in g measured by T1/2. n= 4
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Phospho-LETM1 protects against neuronal death. Our data
support the notion that PINK1-mediated phosphorylation of
LETM1 plays an important role in [Ca2+]m transport. Deﬁcient
PINK1 would lead to [Ca2+]m mishandling and overload, which
can induce mitochondrial permeability transition pore (mPTP)
opening and contribute to neuronal death11, 12. We therefore
investigated the role of PINK1-mediated LETM1 phosphorylation
in mPTP opening and neuronal death/degeneration. First, we
showed that the level of LETM1 protein was not signiﬁcantly
changed in neurons with MPP+ treatment (Supplementary
Fig. 11a, b) and knockdown of LEMT1 by SiLETM1-S2 and
-S3 sensitized cultured neurons to calcium-induced mPTP
opening (Fig. 5a, b) and MPP+ treatment (Fig. 5c). Second,
expression of LETM1-WT and LETM1-T192E but not LETM1-
T192A or GFP control in PINK1 WT neurons protected against
calcium-induced mPTP opening (Fig. 5d, e) and MPP+ challenge
(Fig. 5f). However, only expression of LETM1-T192E in PINK1
KO neurons resulted in protection against calcium-induced
mPTP opening (Fig. 5d, e) and MPP+ challenge (Fig. 5f). Simi-
lar ﬁndings were observed in an in vivo MPTP model. We
examined the effects of expression of adenoviral GFP, LETM1-
WT, T192A, and T192E in DA neuronal loss in MPTP injected
mice. We veriﬁed the expression of LETM1 and its mutants in the
substantia nigra pars compacts (SNc) of mice by WB (Supple-
mentary Fig. 12a) and immunoﬂuorescence (Supplementary
Fig. 11b) after adenoviral injection. In the saline-injected control
group, expression of adeno-LETM1-WT and T192A and T192E
did not lead to signiﬁcant neuronal death in the SNc of WT and
KO mice (Fig. 6a, b). Expression of LETM1-WT and T192E but
not T192A signiﬁcantly protected DA neurons from loss com-
pared to the GFP control in PINK1 WT mice, whereas only
expression of LETM1-T192E but not WT and T192A protected
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Fig. 5 The protective role of phospho-LETM1 at Thr192 in mPTP opening and neuronal death. a, b Primary cortical neurons were transfected with control
SiCon, SiLETM1-S2, and -S3 and then were processed to calcium-induced mPTP opening assay. a Representative average calcein ﬂuorescence traces of
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DA neurons in PINK1 KO mice (Fig. 6a, b). Consistent with this
assessment of survival by TH immunostaining, cresyl violet
staining also showed similar results (Fig. 6c). Taken together, our
in vitro and in vivo data suggests that phosphorylation of LETM1
by PINK1 plays an important role in calcium homeostasis, which
is associated with protection of neurons from exogenous stress.
Discussion
In this study, we demonstrate that PINK1 directly interacts with
LETM1 and phosphorylates LETM1 at Thr192. Phospho-LETM1
at Thr192 not only increases the rate of calcium release/uptake in
liposomes but also facilitates calcium transport in intact mito-
chondria of neurons. PINK1 KO and PD-associated mutant
PINK1-Q456X dramatically decreases phospho-LETM1, resulting
in mitochondrial calcium mishandling and neuronal vulner-
ability. Expression of LETM1-T192E, a phospho-mimetic mutant,
but not LETM1-WT rescues the mitochondrial calcium mis-
handling in PINK1 KO neurons. Expression of LETM1-WT and
T192E protected MPP+/MPTP-induced neuronal death in PINK1
WT mice, while only LETM1-T192E protects neurons in PINK1
KO mice. Interestingly, LETM1-WT could increase calcium
transport in artiﬁcial liposome but expression of LETM1-WT (or
192A) did not rescue calcium transport in mitochondria and did
not prevent neuronal death in PINK1 KO mice. The reason for
this is unclear but may reﬂect a differential response in artiﬁcial
liposome vs. mitochondrial context. For example, LETM1-WT is
present endogenously in neurons, which may impact the response
of exogenously expressed LETM1 constructs. Nonetheless, our
data shed light on an important mechanism by which PINK1-
mediated LETM1 phosphorylation plays a critical role in
mediating mitochondrial calcium transport associated with neu-
ronal survival. Deﬁcient or mutant PINK1 reduces LETM1
phosphorylation and consequently results in mitochondrial cal-
cium mishandling.
Mitochondrial Ca2+ transport is complex and cell type
dependent34. In this regard, the MCU complex plays an impor-
tant role in mitochondria calcium uptake. However, the MCU
complex, due to its low Ca2+ afﬁnity, demands high local Ca2+
concentrations above the micromolar level, which are achieved by
a close proximity to ER–mitochondria contact sites and regulates
ER/mitochondria Ca2+ transfer. Other than the MCU complex,
mitochondrial Ca2+ uptake via rapid mode (RaM) is an alter-
native/additional pathway suggested to work when [Ca2+]c
increased only above 200 nM26, 31, 35. Calcium signaling in neu-
rons not only involves ER but is also dominated by Ca2+ inﬂux
through voltage- and ligand-gated ion channels36. Ca2+ could be
directly transported into mitochondria by non-MCU mechanisms
and LETM1 may play a critical role in this mitochondrial calcium
uptake pathway. In support of this, our data show that Ac sti-
mulation can activate Ca2+ inﬂux from extracellular calcium
sources and results in PINK1- and LETM1-dependent mito-
chondrial Ca2+ management. It is important to note that there is
some controversy on whether LETM1 acts directly as a Ca2+/H+
exchanger. Accordingly, we cannot rule out that the observed
calcium regulatory effects by PINK1 may be indirectly reliant on
LETM1, at least in a cellular context. In this regard, LETM1 has
also been suggested to regulate K+37. In addition, mitochondrial
Na+/Ca2+ exchanger (NCX) also mediates [Ca2+]m extrusion and
it has been recently reported that the activity of a mitochondrial
Na+/Ca2+ exchanger NCLX is impaired in PINK1 deﬁciency,
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which can be rescued by PKA33. However, our data support that
LETM1 and NCLX are involved in [Ca2+]m extrusion in a
manner that is likely independent. Nonetheless, our data strongly
support a model by which PINK1 regulation of LETM1 is critical
for neuronal death induced by mitochondrial stress both in vitro
and in vivo.
Neurodegenerative disorders including PD exhibit dysregula-
tion of calcium homeostasis due to excitotoxicity, perturbed
energy metabolism and oxidative stress, and compromised cel-
lular calcium-regulating systems38. It has been suggested that
adult DA neurons engage L-type channels permeable to calcium
to drive pacemaking, leading to elevated intracellular calcium and
neuronal vulnerability39. In stressed neurons, extracellular cal-
cium enters the cell via calcium permeable channels (i.e., gluta-
mate receptors) elevating [Ca2+]C and [Ca2+]m38. Accordingly,
one interesting model is that PINK1-mediated phosphorylation of
LETM1 at Thr192 could facilitate [Ca2+]m extrusion to prevent
sustained [Ca2+]m accumulation and protect neurons from stress
and death. At least in models of mitochondrial stress, this appears
to hold true. However, an important caveat is that MPP+/MPTP
models of degeneration may not accurately reﬂect the true age-
dependent processes in human PD. In this regard, the study of
degenerative processes in model rodent systems is hampered by
the lack of robust DA degeneration with respect to genetic forms
of PD like with PINK1 loss40. However, it is intriguing to spec-
ulate that because of the proposed pacemaking capacity of DA
neurons, a PINK1-LETM1 regulatory mechanism may be parti-
cularly critical in PD. In this model (Supplementary Fig. 13), we
hypothesize that mutant or deﬁcient PINK1 results in decreased
phosphorylation of LETM1, consequently accelerating [Ca2+]m
mishandling and overload, rendering neurons vulnerable to
stress.
Methods
Antibodies. The following antibodies were used: anti-FLAG (Sigma, Cat: F3165,
dilution 1:10,000), anti-Myc (Abcam, Ab9106, 1:2500), anti-Phosphothreonine
(pThr, Thermo Fisher, 71-8200, 1:2500); anti-Phosphoserine (pSer, Thermo Fisher,
61–8100, 1:2500); anti-LETM1 (Santa Cruz, mouse sc-514136, 1:2500 or Novus
Biologicals, rabbit NBP1-33433, 1:10,000). Anti-PINK1 (Abgent, mouse AM6406a,
1:5000 and Novus Biologicals, rabbit BC100–494, 1:5000), anti-Tyrosine hydro-
xylase (TH, EMD Millipore, AB152, 1:1000), anti-MCU (Cell Signaling, 14997,
1:10,000), anti-NCLX (Abcam, ab136975, 1:5000). Special custom phospho-
LETM1 at Thr192 (pT192) polyclonal antibody was generated and puriﬁed from a
rabbit immunized with carrier protein-conjugated phosphopeptide,
CNGHTLpT192RRERR (residues 187–197 of human LETM1, NP_036450.1), using
standard protocols by Biogenes (Berlin, Germany, dilution 1:2500).
Plasmid construction and virus production. The full open reading frame com-
plimentary DNA clone of human LETM1 was purchased from Origene and was
cloned into pCMV-3Tag-2a (Myc-Tag) and sequence was veriﬁed by DNA
sequencing. LETM1 mutants were generated using QuickChange Site-Directed
Mutagensis Kit (Stratagene, USA). LETM1 variants were engineered into the
pGEX4T-1 or pET28a vector for preparation of GST- or His-tag fusion proteins41.
LETM1 variants and PINK1 were cloned to pAdtrack-CMV with 3XFLAG at C-
terminus for preparation of recombinant adenovirus as previously described42. The
viral constructs expressing 3XFLAG-LETM1 variants and GFP are controlled by
separate CMV promoters. The adenoviruses were produced using pAdEasy system
as previously described43.
Bacterial protein puriﬁcation and in vitro kinase assay. For production of
bacterial recombinant protein, transmembrane domains in amino-acid residues
1–111 of PINK1 were deleted by plasmid cloning and designated ΔN-PINK1. Only
N-terminus (amino-acid residues 1–204) of LETM1 without transmembrane
domains and C-terminus were produced by cloning and designated N-LETM1. The
transmembrane domain (TM; amino-acid residue 205–227) of human LETM1
were deleted and designated ΔTM-LETM1. All GST- or His-tagged fusion proteins
were expressed in Escherichia coli and puriﬁed using Sepharose 4B agarose (GE
Healthcare, USA) or Ni-NTA Agarose (Qiagen Inc, Canada) respectively, as
per manufacturer’s instruction. The PINK1 kinase assay with LETM1 variants was
performed as previously described44, 45. Brieﬂy, 10 µg GST-N-LETM1 or His-
ΔTM-LETM1 variants with 2 µg His-ΔN-PINK1 was incubated at 30 °C for 6 h in
40 µl of reaction buffer containing 50 mM Tris-HCL (pH 7.4), 10 mM MgCl2, 2
mM MnCl2, 0.5 mM Calcium, 2 mM DTT and 0.1 mM ATP. The reactions were
subjected to WB with pSer, pThr, or pT192 antibodies.
Immunoprecipitation. Cells or samples were harvested in lysis buffer (50 mM
Tris-HCl (pH 7.4), 100 mM NaCl, 2 mM EDTA, 1 mM DTT, 1% Triton X-100, and
0.1% SDS) supplemented with protease inhibitors. IPs were performed through
incubation of 2 µg antibodies with lysates (2 mg protein) at 4 °C for 2 h followed by
incubation with protein A beads (Sigma, USA) at 4 °C for 2 h. The washed samples
were analyzed by Western blotting using TrueBlot secondary antibodies (Rockland
Immunochemicals Inc). Some IPed FLAG-tagged proteins were eluted with
3XFLAG peptide (Sigma) according to the manufacturer’s instructions.
Artiﬁcial liposomes. The calcium transport activity of LETM1 was measured as
calcium released from artiﬁcial liposomes as described previously with minor
modiﬁcation17, 27, 46. Liposomes were reconstituted by mixing 100 mg/ml asolectin,
10 mg/ml cardiolipin in solubilization solution (Tris 50 mM, pH 7.4, 2% Triton-
100, 2 mM calcium, EDTA 0.5 mM) and sonicated until the solution was clear.
Combined with varied puriﬁed LETM1 proteins, the liposomes were incubated at
room temperature for 1 h. Detergent was then removed by passing Amberlite
XAD-2 (Sigma) columns three times. Extraliposomal solutions were changed by
passing eight times through Sephadex G-25 (GE Healthcare) columns swelled with
TE buffer (Tris 50 mM/EDTA 0.5M). The free [Ca2+] was measured (excitation at
488 nm and emission at 530 nm) in a plate reader by loading 10 μM Fluo-4 pen-
tapotassium salt (Invitrogen). The calcium uptake assay in liposome was also
performed. Liposomes were reconstituted by mixing 20 mg/ml 3:1 POPE (850757P;
Avanti Lipids Polar)/POPG (840457P, Avanti Lipids Polar) in solubilization
solution (Tris 50 mM, pH 7.4, 2% Triton-100, EDTA 1mM). The rest of the
procedure is similar to the calcium release assay. Extraliposomal solutions con-
tained Tris 50 mM/EDTA 0.5 mM. Ca2+ was added to extraliposomal solutions
to create the initial 750 nM free [Ca2+] (CaCl2 0.47 mM/EDTA 0.5 mM) and then
the free [Ca2+] was measured (excitation at 488 nm and emission at 530 nm) in
a plate reader by loading 10 μM Fluo-4 pentapotassium salt (Invitrogen). [Ca2+]
was calculated using WEBMAXC (http://www.stanford.edu/~cpatton/webmaxcS.
htm).
Neuronal cultures with survival assay and RNA interference. Primary culture
of mouse cortical neurons was carried out as described previously47, 48. For
infection, 24 h after initial plating the cortical neurons were infected with adeno-
virus (MOI 100). Two days after infection, cortical neurons were subjected to
survival determination following exposure to 75 μM MPP+ for 24 h. For survival of
infected neurons, GFP-positive neurons were assessed for nuclear integrity as
determined by Hoechst 33258 (0.5 ng/ml) staining. Neurons with punctate or
condensed nuclei were assessed as dead. Survival was expressed as the percentage
of live cells to total cells. SiRNA to mouse LETM1 was produced utilizing the
Silencer siRNA Construction Kit (AM1620, Thermo Fisher Scientiﬁc) as
per manufacturer’s instruction. The sequences of sense strand siRNA to LETM1
and scramble control are: S1 (5′-UGAGGAAAUCAUGC-GUUUU-3′); S2 (5′-
GGAGGAGAUUGACAUCCUC-3′); S3 (5′-GCAAAUCAAGCACA-UUCCA-3′);
scramble control siRNA (5′-GUAGCACGCGUA ACUGUCU-3′). Neurons were
transfected with 30 pmol/well (24 well plate) siRNA to mouse LETM1 (SiLETM1)
using Lipofectamine 2000 (Invitrogen, USA) for 2 days and re-transfected once at
3 days.
TMRE staining for mitochondrial membrane potential. Cortical neurons were
loaded with 200 nM tetramethylrodamine methylester (TMRM; T669; Thermo
Fisher) in imaging buffer (20 mM HEPES, 135 mM NaCl, 5 mM KCl, 1 mM CaCl2,
30 mM D-glucose, 10 mM succinate, pH 7.4) for 30 min at room temperature, and
the dye was present during the imaging experiment analyzed by a Zeiss 510 meta
confocal microscope.
Mitochondrial Ca2+ imaging in individual neurons. Mitochondrial Ca2+ imaging
in individual primary cortical neurons employed Rhod-2 dye, which is cationic and
preferentially accumulated in the mitochondria28. Cortical neurons at DIV3–4 on
coverslip infected with adenovirus were loaded with Rhod-2-AM (Invitrogen) 1 µM
and 0.01% (w/v) pluronic acid in imaging buffer (20 mM HEPES, 135 mM NaCl, 5
mM KCl, 1 mM CaCl2, 30 mM D-glucose, 10 mM succinate, pH 7.4) at room
temperature for 30 min. Subsequently, cells were washed with imaging buffer and
further incubated for 60 min at 37 °C for de-esteriﬁcation of dye. Mitochondrial
Ca2+ imaging experiments were performed in the imaging chamber (Warner
Instruments) at 37 °C with Zeiss AxioObserver. D1 Microscope with ×40 objective.
Rhod-2 was excited at 543 nm, and emission measured at 580 nm. The increased
mitochondrial calcium was stimulated by 100 µM Ac. The images were captured in
a time lapse model at 2s intervals for 2 min and neurons were stimulated at the
10th frame of recording. Relative increase in ﬂuorescence intensity was normalized
by ﬂuorescence at the resting condition (ΔF/F0). Data were generated and analyzed
with Zeiss microscope Axiovision rel 4.8 software. The rate of uptake or extrusion
of mitochondrial calcium was expressed as T1/2 calculated by Logarithmic (LOG)
function formatted as T1/2= Exp[(Y1/2–b)/a] in Microsoft Excel 2010. Data were
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presented as the traces of average values for all data points generated from a
minimum of 20 neurons per experiment and at least ﬁve independent experiments.
FRET-based mitochondrial calcium imaging. TN-XXL is a genetically encoded
FRET calcium sensor and based on the calcium binding protein troponin C linking
cyan ﬂuorescent protein (CFP) and Citrine Cp174 ﬂuorescent protein (one YFP).
We produced a mitochondrial targeted 4XmTG-TN-XXL construct, where four
mitochondrial targeting sequences (mTGs) derived from the subunit VIII of
human cytochrome c oxidase were fused with the N-terminal of TN-XXL. 4XmTG-
TN-XXL (kindly provided by Dr. Oliver Griesbeck, Max Planck Institute of
Neurobiology, Martinsried, Germany) was subcloned into lentiviral pLVX-
AcGFP1-N1 vector (Clotech, Cat No: 632154) with deletion of GFP. We also
generated the mito-targetted PLVX-4XmTG-Cherry as control and PLVX-LETM1-
3XFLAG-T2A-Cherry WT, T192A, and T192E constructs with deletion of GFP.
T2A is a self-cleaving 2A peptide37. Lentiviruses were generated by PLVX, pPAX2,
and pMD2.G system. Lenti-4XmTG-TN-XXL were co-infected with lenti-4XmTG-
Cherry, LETM1-3XFLAG-T2A-Cherry WT, T192A, and T192E in neurons (MOI
10) at DIV 1 for 5–7 days before calcium imaging.
For FRET-based mitochondrial calcium imaging, all FRET microscopic
observations were performed on a Zeiss 510 meta confocal microscope at 37 °C.
Donor (CFP) was excited at 458 nm and detected in a bandwidth of 470–500 nm
(CFP channel), whereas the excitation at 514 nm and emission at 505–550 nm were
used for detecting acceptor (YFP) (YFP channel). For FRET, the excitation was at
458 nm and detection at 505–550 nm (FRET channel). CFP and FRET emission
channels were recorded simultaneously by passing through a long-pass dichroic
mirror (515 nm). The images were captured in a time-lapse model at 3s intervals
for 2 min and neurons were stimulated at the 5th frame of recording by 100 µM Ac.
Images were analyzed using Image J software. The Intensity of FRET/CFP was
calculated as FRET ratio. Relative increase in FRET ratio was normalized by the
resting condition (ΔR/R0). The rate of uptake or extrusion of mitochondrial
calcium was expressed as T1/2 calculated by LOG function formatted as T1/2= Exp
[(Y1/2–b)/a] in Microsoft Excel 2010. Data were presented as the traces of average
values for all data points generated from a minimum of 10 neurons per experiment
and at least four independent experiments.
Measurement of the mPTP opening. mPTP opening was assessed by the
quenching of calcein ﬂuorescence with cobalt30. PINK1 WT or KO neurons were
loaded with Calcein-AM (1 μM, Molecular Probes) at 37 °C for 15 min and CoCl2
(2 mM, Sigma) was added for further 30 min. Neurons were washed and then
permeabilized with 5 μM digitonin in 5 μM Ca2+ in imaging buffer (20 mM
HEPES, 135 mM NaCl, 5 mM KCl, 30 mM D-glucose, 10 mM succinate, pH 7.4) to
induce mPTP opening. Images were captured with the Zeiss AxioObserver. D1
Microscope in a time-lapse model at 3s intervals for 2 min. Relative calcein
ﬂuorescence intensity was normalized to the resting condition (ΔF/F0) and T1/2
was calculated. Data were generated and analyzed with the Zeiss microscope
Axiovision rel 4.8 software.
Animals with viral delivery and MPTP administration. PINK1-deﬁcient mice
(maintained on a C57BL/6 background) and wild-type littermates were generated
by breeding their heterozygous counterparts. Genotyping information was reported
previously49. Mice were housed two to ﬁve animals per cage with a 12-h light/dark
cycle (lights on from 0700 to 1900 h) at constant temperature (23 °C) with ad
libitum access to food and water. All animal experiments conformed to the
guidelines set forth by the Canadian Council for the Use and Care of Animals in
Research (CCAC) and the Canadian Institutes for Health Research (CIHR) and
with approval from the University of Ottawa Animal Care Committee.
We have previously shown that adenoviruses were targeted unilaterally to DA
neurons of SNc from the striatum by retrograde transport using a well-established
adenoviral-mediated gene delivery approach14. About 52 male PINK1 WT and 52
male KO mice of 8–12 weeks were randomly allocated to four groups, respectively.
A single unilateral injection of each virus expressing GFP, LETM1-WT, T192A, or
T192E (2 µl, 1 × 107 particles per µl) was delivered to the right striatum (0.5 mm
rostral, 2.2 mm right of bregma, and 3.4 mm below the skull surface) of 8-week-old
male mice using a syringe pump system 7 days before MPTP administration. To
examine the viral expression in TH neurons, the samples extracted from SNc of
post 7 days virus-injected mice were subjected to Western blotting. Coronal
sections (14 µm thickness) of the ventral midbrain were double labeled using
speciﬁc primary antibody to GFP (Abcam) or TH (Millipore).
Mice received one intraperitoneal injection of MPTP·HCl per day (30 mg/kg,
Sigma, USA) for 5 consecutive days50–53. Control mice received an equivalent
volume of 0.9% saline. Assessment of dopamine neuron survival was performed
blindly 2 weeks after the start of the MPTP injection by immunohistochemical
analyses.
Immunohistochemistry and immunoﬂuorescence. Mice were perfused trans-
cardially and brains were ﬁxed in 4% paraformaldehyde and cryoprotected as
previously described54. Free ﬂoating serial coronal sections (14 µm thickness) of the
ventral midbrain were collected. Sections were then incubated with TH antibody
(1:1000) for 24 h at 4 °C. Immunoreactivity was visualized by using an
avidin–biotin complex peroxidase/3,3′-diaminobenzidine (DAB) reaction. For
double-labeling immunoﬂuorescence, samples were double labeled with primary
antibody to GFP (Abcam) or TH (Millipore) and visualized using either Alex-488-
conjugated anti-rabbit IgG (1:200) or Alex-594-conjugated anti-mouse IgG (1:200).
Quantiﬁcation of dopaminergic neuronal loss. The number of DA (TH positive)
neurons was only counted from the sections in the region containing the medial
terminal nucleus (MTN) because this region has been previously shown to express
the highest level of virus-mediated gene expression after intrastriatal infection50.
We also used the MTN as a landmark to evaluate consistent levels of SNc. Neurons
in the ipsilateral and contralateral side to the viral injection were assessed as
previously described50. At least three sections per animal were analyzed. In parallel,
cresyl violet staining was performed to validate determination of nigral counts as
previously described50. The anatomical localization of SNc was referenced by TH
staining.
Statistical analysis. Statistical differences between multiple groups of data were all
analyzed with nonparametric Kruskal–Wallis one-way ANOVA test using
GraphPad Prism v7.03 program. The data are presented as median. Exact p-value is
indicated in the graph if p< 0.05.
Data availability. All data generated or analyzed during this study are either
included in this published article (and its Supplementary Information ﬁles) or
available from the authors.
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